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Keratoconus (KC) is a progressive degenerative inflammatory-related disease of the human cornea leading to decreased visual
function.The pathogenesis of KC remains to be understood. Recent genetic studies indicate that gene variants of an inflammation-
related molecule, hepatocyte growth factor (HGF), are associated with an increased susceptibility for developing KC. However
HGF protein expression in KC has not been explored. In this initial study, we investigated late-stage KC and control corneas for the
expression of HGF and its receptor mesenchymal-epithelial transition factor (c-Met/Met). KC buttons (∼8mm diameter) (𝑛 = 10)
and whole control corneas (𝑛 = 6) were fixed in 10% formalin or 2% paraformaldehyde, paraffin embedded and sectioned. Sections
were immunolabelled with HGF and c-Met antibodies, visualised using immunofluorescence, and examined with scanning laser
confocal microscopy. Semiquantitative grading was used to compare HGF and c-Met immunostaining in KC and control corneas.
Overall, KC corneas showed increased HGF and c-Met immunostaining compared to controls. KC corneal epithelium displayed
heterogeneous moderate-to-strong immunoreactivity for HGF and c-Met, particularly in the basal epithelium adjacent to the cone
area. Taken together with the recent genetic studies, our results further support a possible role for HGF/c-Met in the pathogenesis
of KC.
1. Introduction
Keratoconus (KC) is the most common primary human
degenerative corneal disease with a prevalence of around 1 in
2000 worldwide [1]. It is bilateral, asymmetric, and progres-
sive, leading to corneal thinning and irregularity [2]. Onset
primarily occurs in the 2nd decade of life and is associated
with significant decreasing visual function [2] and morbidity
[3]. KC is the main indication recorded for corneal grafts in
Australia [4], and currently its progression can only be halted
through surgical interventions including collagen cross-
linking that stiffens the cornea using riboflavin and UVA [5].
More recently a surgical procedurewas developed transplant-
ing isolated Bowman’s layer from donor corneas to KC eyes
as a further late-stage intervention [6].
The histopathology of KC is well described and includes
epithelial and stromal thinning within the apical cone region,
breaks in the Bowman’s layer, focal fibrosis, and anterior
stromal keratocyte apoptosis [2, 7]. However the underlying
pathogenesis of KC remains unclear. Recent evidence indi-
cates a role for inflammation in the disease, with increased
recruitment of inflammatory cells (e.g., macrophages, lym-
phocytes, and antigen presenting cells) [8] and inflammatory
markers such as interleukin-1 (IL-1) and transforming growth
factor-beta (TGF-𝛽) [9] observed in KC corneal tissue sec-
tions. Increased expression of inflammatory markers such as
interleukin-6 (IL-6), tumour necrosis factor alpha (TNF-𝛼),
andmatrixmetalloproteinase 9 (MMP-9) has also been found
in tears collected fromKC patients compared to controls [10].
Furthermore, a recent review examining the biochemical
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Table 1: Characteristics of KC patients.
aKC Gender Age at diagnosis (yrs.) Age at surgery (yrs.) Contact lenses (Y or N) History of allergy and/or atopy(Y or N)
bDALK (Y or N)
1 F 24 32 Y N N
2 F 23 30 N Y asthma Y
3 F 30 37 N N Y
4 M 27 32 N Y atopy and asthma N
5 M 25 32 N N Y
6 F 18 21 N Y atopy and asthma N
7 M 24 28 Y N N
8 M 24 43 Y N N
9 F 20 31 Y N N
10 F 32 38 Y N Y
aGrade 4 KC: severe; VA >6/7.5 with contact lens correction; severe corneal thinning and Munson’s sign.
bDALK: deep anterior lamellar keratoplasty.
changes in KC proposed a “two-hit hypothesis” with a
“genetic predisposition to the corneal disease and a secondhit
that may induce abnormalities of inflammatory components”
[11].
Single nucleotide polymorphism (SNP) refers to a change
in a single nucleotide within a DNA sequence and is the most
common type of genetic variation observed in the human
genome [12]. SNPs have been widely studied as genetic mark-
ers for human disease. Two parallel genome-wide association
studies identifying potential SNPs associated with KC, using
independent sample cohorts, reported a significant associ-
ation between KC and the hepatocyte growth factor (HGF)
gene, identifying two single nucleotide polymorphisms
(SNPs; rs3735520 and rs17501108) in the promoter region
[13]. Further, Burdon et al. (2011) also examined HGF protein
abundance in the serum of controls correlating to the
rs3735520 genotype and found a significant increase in HGF
serum protein associated with the minor allele T [13].
HGF is a pleiotropic growth factor that activates the
HGF/c-Met pathway after binding to its receptor, mesenchy-
mal-epithelial transition factor (c-Met/Met). Once activated,
downstream pathways such as mitogen-activated protein
kinase (MAPK) cascades, PI3K-Akt axis or Janus kinase/sig-
nal transducers, and activators of transcription (JAK/STAT)
pathways may be activated [14]. HGF has been implicated
in several cellular roles within the cornea. For example,
together with MMP-1, HGF is reported to initiate human
corneal epithelial cell migration in vitro [15], and exoge-
nous HGF has been found to promote the proliferation of
both corneal epithelial and endothelial cells [16]. In injured
rabbit corneas, Wilson et al. (1999) reported an obvious
increase of HGF mRNA expression in keratocytes and c-Met
mRNA expression in epithelial cells compared to unwounded
corneas, suggesting that the HGF/c-Met pathway plays a
role in corneal wound healing [17]. Studying bovine corneal
wound healing in organ culture models, Carrington and
Boulton (2005) showed that HGF delayed epithelial layer for-
mation, together with increased differentiation of keratocytes
tomyofibroblasts, compared with untreated and keratinocyte
growth factor (KGF) treated corneas [18].
The expression of HGF and c-Met proteins in human
KC corneas has not been investigated to date. One study
has reported increased serum HGF expression for at least
the minor allele of HGF SNP rs3735520, associated with
increased potential for developing KC [13]. As a first step in
assessing the role of HGF protein and its receptor (c-Met)
in KC, we used corneal buttons from patients with severe
KC and control human corneas to compare and examine the
distribution and expression of these proteins.
2. Materials and Methods
KC corneal tissue buttons (Vision Eye Institute, Chatswood,
NSW Australia) and donor corneas (Lions New South
Wales (NSW) Eye Bank) were obtained with consent and
approval from the Sydney Eye Hospital Human Research
Ethics Committee (HREC 2013/1041). All procedures were
in accordance with the Declaration of Helsinki. Informed
consent was obtained from all participants prior to collection
of KC buttons. Normal donor corneas were obtained from
the Lions NSW Eye Bank following appropriate consent and
HREC approval.
2.1. Corneal Specimens. Ten corneal buttons were collected
from KC patients (age range from 18 to 32 years) undergo-
ing corneal transplantation at Vision Eye Institute. All KC
patients were diagnosed on the basis of clinical signs and
corneal topography and were classified as KC grade 4 (most
severe stage) (Table 1). Six normal donor corneas (age range
53 to 83 years) were obtained from the Lions NSW Eye Bank
(Table 2).
KC corneal buttons (∼8mm diameter), with the cone
apex location marked, were fixed in 10% neutral buffered for-
malin (NBF). Whole corneas were fixed in 2% paraformalde-
hyde/PBS (pH 7.4). All specimens were paraffin embedded
and cut at 6𝜇m. Sections were collected on Super-Frost Plus














Figure 1: Representative images showing increased HGF expression in basal epithelial cells adjacent to the cone region in KC (a), compared
to the relatively more uniform expression seen in all layers of control cornea epithelium at a similar location (c). Strong HGF stromal staining
(keratocyte and extracellular matrix) is also observed in KC and control corneas (a to c). No immunostaining is apparent in the Ig negative
control (d). (a) Region adjacent to the cone in KC cornea, (b) cone region in KC cornea, (c) central region of control cornea, and (d) Ig negative
control cornea. Epi: epithelium, Stro: stromal. Green: HGF; blue: nuclei.
Table 2: Characteristics of control corneas.







slides (Menzel-Glaser, Saarbruckener, Germany) and dried
before use.
2.2. Immunohistochemistry. Sections were dewaxed and
rehydrated through alcohols to water. For antigen retrieval,
sectionswere incubated in 0.01M citrate buffer (pH6) at 85∘C
for 10 minutes, cooled to 40∘C, and rinsed in Tris-buffered
saline (TBS, pH 7.4) with 0.1% Tween-20 (TBST). Sections
were incubated at room temperature (RT) in 5% bovine
serum albumin (BSA) in TBST for 30 minutes, followed
by incubation overnight at 4∘C in HGF or c-Met primary
antibodies, or appropriate negative controls (Mouse or Rabbit
IgG) (Table 3). After overnight incubation, sections were
washed in TBST and incubated in either goat anti-mouse
Alexa Fluor 488 or donkey anti-rabbit Alexa Fluor 488.
For co-immunolabelling experiments, a separate series of
slides were prepared and HGF visualised with Alexa Fluor
488 and c-Met visualised with Alexa Fluor 594, combined
with nuclear Hoechst stain (Table 3).
Immunolabelling was repeated at least twice per spec-
imen for each antibody, and appropriate Ig controls were
included for each experiment. All slides were mounted in
20% glycerol/PBS, coverslipped, sealed with nail varnish, and
viewed using a Zeiss LSM700 scanning laser confocal micro-
scope and image software (Zen 2011, Carl ZeissMicroImaging
GHBH, Jena, Germany). Where more than one colour was to
be detected, multichannel excitation bleed-through wasmin-
imized using fluorochromes with separated peak excitations.
Emission bleed-through was minimized by multitracking,
where signal crosstalk between neighbouring channels was
corrected by performing a sequential image capture routine.
2.3. SemiquantitativeAnalysis forHGFand c-Met. Semiquan-
titative grading of single-immunolabelled sections was used
to assess the intensity and distribution of HGF and c-Met
immunoreactivity in the corneal epithelium, stroma, and
endothelium. Grading for KC buttons wasmade in the region
adjacent to the cone (Adj) and for control corneas in a similar
central corneal region. Immunolabelling of the thinned cone
area of KC buttons was examined in each specimen but
was not graded for comparison with controls because of
the obviously altered morphology (only 1-2 epithelial layers
present). The grading scale used was based on the intensity
of the immunofluorescence (0 = no staining, 0.5 = very weak,
1 = weak, 2 = moderate, and 3 = strong) and the percentage
(%) area immunolabelled (0 = 0%, 1 = 1% to 10%, 2 = 11% to
50%, and 3 > 50%) as described previously [19]. A final grade
of 0 to 6 (intensity + % area immunolabelled) was then given
for each specimen and this data is used to generate frequency
histograms for HGF and c-Met immunostaining in KC and
control specimens, respectively.
3. Results and Discussion
All KC corneas showed a thickened epithelium adjacent
to the more central cone region (Figures 1(a) and 2(a)),
compared to similar regions in the control corneas (Figures
1(c) and 2(c)), as we previously reported [19]. Only one
to two layers of flattened epithelium were observed within
the cone region (Figures 1(b) and 2(b)). Weak and more
evenly distributed cytoplasmic immunostaining forHGF and
c-Met was detected in the epithelium of control corneas
(Figures 1(c) and 2(c)). In KC corneas, moderate-to-strong
cytoplasmic immunostaining was seen within the basal and
wing cell epithelial layers adjacent to the cone region (green
fluorescence, Figures 1(a) and 2(a)). Only weak-to-moderate
immunostaining of HGF and c-Met was detected in the KC
cone region (Figures 1(b) and 2(b)).
Co-immunolabelling for HGF and c-Met showed that
c-Met (red) was primarily localised in the epithelium of
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Mouse anti-human HGF Santa Cruz Biotechnology, Inc. (Dallas, Texas, USA) 2 𝜇g/mL
Rabbit anti-human c-Met Santa Cruz Biotechnology, Inc. 0.4 𝜇g/mL
Mouse anti-human IgG Zymed Laboratories (Thermo Fisher Scientific, Waltham, Massachusetts,USA) 2 𝜇g/mL
Rabbit anti-human IgG Zymed Laboratories 0.4 𝜇g/mL
Alexa Fluor 488 goat anti-mouse IgG Molecular Probes (Life Technologies, Carlsbad, California, USA) 2 𝜇g/mL
Alexa Fluor 488 donkey anti-rabbit IgG Molecular Probes 2 𝜇g/mL
Alexa Fluor 594 donkey anti-rabbit IgG Molecular Probes 2 𝜇g/mL














Figure 2: Representative images showing increased c-Met expression in basal epithelial cells adjacent to the cone region in KC (a), compared
to the relatively more uniform expression seen in all layers of control cornea epithelium at a similar location (c). Weak c-Met staining is
detected in the stroma in both KC and control corneas (a to c). No immunostaining is apparent in the Ig negative control (d). (a) Region
adjacent to the cone in KC cornea, (b) cone region in KC cornea, (c) central region of control cornea, and (d) Ig negative control. Epi: epithelium;
Stro: stromal. Green: HGF; blue: nuclei.
both control and KC corneas (Figure 3). HGF (green) was
primarily localised within the stroma (both keratocytes and
extracellular matrix) of control and KC corneas (Figure 3).
Weak and relatively uniform immunostaining was observed
in similar regions from control corneas for HGF and c-Met
(Figure 3(a)). However, for KC corneas, increasedHGF stain-
ing (green) was detected in the basal epithelium adjacent to
the cone region and colocalisedwith increased c-Met staining
(red) (Figure 3(d)). Limbal areas of control corneas showed
slightly stronger stromal immunostaining of HGF compared
to the central region of control corneas (Figure 3(b)).
Semiquantitative grading of HGF and c-Met immunos-
taining in KC samples was increased overall compared to the
control corneas for similar regions, as indicated by the skewed
distribution of the frequency histograms (Figures 4(a) and
4(b)). Overall, a greater proportion of KC corneas showed >
grade 3 immunostaining for both HGF and c-met (KC: 70%
and 90%, resp., versus control: 16% and 66% resp.) (Figures
4(a) and 4(b)).
Despite the importance of the HGF/c-Met pathway in
regulating a number of key cellular activities, little is known
about its potential role in normal or KC human corneas. As
a first step to understand the possible role(s) of this pathway,
we examined patterns of HGF and c-Met protein expression
in both control and KC corneas. Higher levels of HGF and
c-Met immunostaining were detected in the basal epithelium
adjacent to the KC cone, compared to the weaker and more
uniform epithelial staining pattern seen in control corneas.
In control corneas, we found HGF expression was
more intense in the stroma compared to the epithelium.
This is consistent with previous studies showing low level
HGF mRNA expression in the human corneal epithelium
compared to keratocytes and endothelium [16, 20]. The
surface of normal rabbit corneal epithelium was reported
to show only low level HGF protein [21]. Our immunos-
taining experiments detected stronger c-Met (HGF receptor)
staining in epithelium compared to keratocytes in control
corneas.This is consistent with c-MetmRNA findings, which
showed that human corneal epithelium, keratocytes, and
endothelium all expressed c-Met, but with highest mRNA
expression in epithelium [16, 20, 21]. These observations
suggest that secreted keratocyte HGFmay preferentially bind
to the epithelium that expresses higher levels of c-Met (HGF
receptor), compared to keratocytes that express low levels
of c-Met, thus potentially regulating key epithelial cellular
activities such as cell proliferation [22].
HGF is reported to be involved in two major processes,
cell proliferation and migration, and inflammatory-related











Figure 3: Representative images of central region of corneas with weak, uniform HGF (green), and c-Met (red) expression in all corneal
layers (a). Patchy staining of HGF and c-Met is colocalised in the basal epithelium of both limbal regions (b) and adjacent to cone region of
KC (c), with KC showing stronger staining than the limbal region. Strong HGF expression is seen within the stroma of both KC (c and d) and
control corneas (a and b). (a) Central region of control cornea, (b) limbal region of control cornea, (c) region adjacent to the cone in KC cornea,
(d) cone region in KC cornea, and (e) Ms and Rb Ig control.
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Figure 4: Frequency histograms for HGF (a) and c-Met (b) expression in KC and control corneas (combined score of staining intensity and
% area coverage; range = 0 to 6). Note the right skewed distribution of HGF and c-Met immunostaining for KC corneas compared to controls.
HGF staining had a combined score >3 in 7/10 (70%) KC corneas, compared to 1/6 (16%) control corneas. c-Met staining with a combined
score >3 was seen in 9/10 (90%) KC corneas compared to 4/6 (66%) control corneas.
signalling cascades. HGF is a potent enhancer for corneal
epithelial cell proliferation [16] and migration [23] in vivo,
and increased HGF and c-Met mRNA expressions have been
detected during corneal wound healing [16]. Increased HGF
protein expression has been detected in the whole corneal
epithelium, keratocytes, and tears of wounded compared to
unwounded rabbit corneas [21]. HGF mRNA expression was
also upregulated in the lacrimal gland when studying injured
compared to unwounded rabbit corneas [17]. No difference
in c-Met immunostaining was detected between wounded
and unwounded rabbit corneas [21]. In secondary injured
KC and control corneas, HGF expression in the stromal cells
was reduced [24]. This was suggested to be most likely due
to normal tissue repair pathways already being damaged
or compromised, implying involvement of HGF in tissue
regeneration [24]. These studies also suggested that lacrimal
gland and keratocyte-derived HGF are closely associated
with corneal tissue repair [17, 24]. In KC corneal epithelium,
we observed increased HGF in the region adjacent to the
cone, as well as increased c-Met; however it remains to be
determined whether the increased expressions of HGF and
c-Met observed are directly involved in KC pathogenesis or
are secondary responses.
Poorly regulated and overexpressed HGF may be detri-
mental to tissues, related to the involvement of HGF in
inflammation. For example, delayed formation of the epithe-
lium layer and increased formation of stromal myofibroblasts
have been detected during rabbit corneal wound healing,
for corneas treated with recombinant HGF [18]. Applying
recombinant HGF to corneas of mice with Pseudomonas
aeruginosa keratitis also worsened the disease progression,
with a significantly higher grade of corneal opacity and
thinning compared to PBS-treated corneas [25]. In vitro treat-
ment of corneal stromal keratocytes with proinflammatory
interleukin- (IL-) 1𝛽 increasedHGF mRNA and protein pro-
duction [26]. Elevated cornealHGF expression also enhanced
proinflammatory cytokines anddecreased anti-inflammatory
cytokines in Pseudomonas aeruginosa keratitis in mice, most
likely under the control of inflammatory cytokines and cell
growth kinases [25].
KC has traditionally been described as a noninflamma-
tory degenerative condition. However, emerging evidence
clearly indicates that inflammation-related processes within
the epithelium and stroma are involved in the pathogenesis of
KC. Significant increases in proinflammatory molecules such
as IL-6, IL-4, IL-5, IL-8, and IL-12 [27–29], MMP-1, MMP-3,
MMP-7, and MMP-13 [28], and chemokine C-C motif ligand
5 (CCL5) [29] and significantly decreased levels of lactoferrin,
serum albumin, and secreted IgA (sIgA) have been reported
in KC compared to control tears [30]. Keratocytes in KC
are reported to express more IL-1𝛼 receptors than controls
[31], and one group has proposed that keratocyte apoptosis
observed in KC may be induced by the binding of IL-1
receptors secondary to increased levels of IL-1 associated
with epithelial trauma, for example, due to eye-rubbing [32].
Most recently, increasedmRNA expression ofMMP-9 and its
inducer proteins IL-6 andTNF-𝛼were detected inKCcorneal
epithelium in an Indian cohort (>100 patients) compared to
healthy controls (𝑛 = 20), and tear protein levels of MMP-
9 and IL-6 were also increased in KC [33]. Treatment with
topical cyclosporine A (an immunosuppressant) in a small
group ofKCpatients (𝑛 = 20) reduced the tear levels ofMMP-
9 and appeared to halt the progression of KC, consistent with
the involvement of inflammation in KC pathogenesis [33].
The link betweenHGF variants and KC susceptibility was
first reported by Burdon et al., (2011) and then confirmed
in an independent European cohort which replicated the
association of SNP rs3735520 and detected a new HGF SNP
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rs2956540 [34]. In addition, an independent study of an
Australian population of European descent (𝑛 = 830) focused
on the HGF locus and detected a different SNP (rs4954218)
significantly associated with KC [35]. The actual function of
these HGF SNPs is unclear. However, a study of rs3735520
implicated a possible regulatory effect of this SNP for HGF
protein expression in serum from KC patients [13]. As the
SNPs identified to date are all located in the noncoding
region of the gene (rs3735520, rs17501108, and rs1014091 in the
upstream of HGF and rs2286194 in the intron between exon
8 and exon 9), it is likely that they will affect gene expression
through mechanisms such as RNA splicing, transcription
factor binding, and miRNA regulation [36]. Our results
provide evidence of increased HGF protein in KC epithelium
compared to control corneal epithelium; however the role of
the reported HGF SNPs in the increased protein expression
is unclear and will be further investigated.
4. Conclusion
Previous studies showed an independent, repeatable associ-
ation between certain SNPs and HGF in KC [13, 34, 35]. The
SNP variations detectedwere located in the noncoding region
ofHGF consistent with a role for these SNPs in the regulating
HGF expression, and increased serum HGF expression asso-
ciatedwith theminor SNP allele has been reported [37]. In the
current study, we showed increased HGF protein expression
within KC corneal epithelium. Taken together previous SNP
studies, these observations indicate that the HGF/c-Met
pathway may be involved in the pathogenesis of KC. Further
studies investigating how the HGF/c-Met pathway may be
altered in KC, including the associations between SNPs and
protein expression and the role of inflammation requires
further investigation. Studies on the downstream signalling
pathways regulated by HGF/c-Met, such as MAPK cascades,
the PI3K-Akt axis, and the JAK/STAT pathway may help
to identify the potential role of this pathway in KC and in
normal corneal homeostasis.
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